• Status: Closed

  • Key features: Investment of up to £10m in a two-phase competition to promote the development of new diagnostic products and services for use in stratified medicine.

  • Programme: SBRI

  • Award: Up to £10m

  • Opens: 07 Sep 2015, 00:00

  • Registration closes: 28 Oct 2015, 12:00

  • Closes: 04 Nov 2015, 12:00

  • Support phone number: 0300 321 4357

Stratified medicine: connecting the UK infrastructure

Summary

Innovate UK is to invest up to £10m in a two-phase competition to promote the development of new diagnostic products and services for use in stratified medicine.

This SBRI competition aims to accelerate and/or increase the development and adoption of innovative diagnostic tools in order to offer better targeted treatment to patients within the UK healthcare system. It also aims to demonstrate the benefits of companies working within the UK ‘enabling infrastructure', which is made up of specialist organisations that can help companies understand healthcare needs and design, evaluate and deliver their products and services into the NHS.

Up to £2m is available for phase 1 of the competition and up to a further £8m may be available in a second phase to further develop successful phase 1 projects. The competition is open to all organisations that can demonstrate a route to market for their solution. Successful organisations will attract a 100% funded development contract of up to £150,000 over nine months in phase 1, with the potential to apply for up to £2m over a further three years in phase 2.

Scope

We will support projects that seek to develop tests capable of classifying patients into groups and selecting them for a clinical treatment (or treatments) currently available in the UK.

We are looking to fund projects that include the following:

  • a diagnostic test that will lead to better treatment for patients

  • a description of how the company will interact with ‘enabling' organisations within the UK to overcome barriers to adoption of their product, including changes to clinical care pathways where appropriate

  • an initial draft of the development plan for preparing the product for market (this will need to be in more depth in phase 2)

Out of scope

In this competition we are not funding projects covering:

  • the development of diagnostic tests that do not give rise to patient stratification

  • diagnostic tests for treatments that are still in development

  • biomarker discovery experiments

Key dates

Competition opens 7 September 2015
Briefing event 15 September 2015
Registration deadline 28 October 2015 noon
Deadline for applications 4 November 2015 noon
Contracts awarded January 2016

 

Supporting documents & links